Qi Bin Liang
Hoofd Techniek/Wetenschap/O&O bij GENOR BIOPHARMA HOLDINGS LIMITED
Profiel
Qi Bin Liang is the founder of CMAB BioPharma (Suzhou) Inc. He is currently working as the Chief Technology Officer at Genor Biopharma Holdings Ltd.
He completed his graduate degree from the University of Idaho and his undergraduate degree from East China University of Science & Technology.
Actieve functies van Qi Bin Liang
| Bedrijven | Functie | Begin |
|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-10-2021 |
CMAB BioPharma (Suzhou) Inc.
 CMAB BioPharma (Suzhou) Inc. Miscellaneous Commercial ServicesCommercial Services CMAB BioPharma (Suzhou) Inc. develops and manufactures biological products. Its services include process development, GMP manufacturing, aseptic drug and quality development. The company was founded by Qibin Liang in June 2017 and is headquartered in Suzhou, China. | Oprichter | - |
Opleiding van Qi Bin Liang
| University of Idaho | Graduate Degree |
| East China University of Science & Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
CMAB BioPharma (Suzhou) Inc.
CMAB BioPharma (Suzhou) Inc. Miscellaneous Commercial ServicesCommercial Services CMAB BioPharma (Suzhou) Inc. develops and manufactures biological products. Its services include process development, GMP manufacturing, aseptic drug and quality development. The company was founded by Qibin Liang in June 2017 and is headquartered in Suzhou, China. | Commercial Services |
